This announcement is a separate document:
自愿披露关于GB08注射液I期临床试验完成首例受试者入组的公告
Announcement on voluntary disclosure of the completion of the first subject enrollment in the phase I clinical trial for GB08 injection.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated